ESLA
Estrella Immunopharma Inc.
0.4175$
-0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -65.5% | -8.6% | -48.4% | -16.1% | -15.9% | -22.2% | +21.9% | +18.2% | -9.8% | +15.1% | -50.1% | |
| – | -83.7% | +93.8% | -48.4% | -49.8% | -26.6% | -42.4% | +56.8% | +36.7% | -17.1% | +28.6% | -15.4% | |
| – | -59.1% | -47.7% | -11.9% | -56.8% | -49.0% | -54.0% | +212.4% | +23.5% | -14.9% | +39.2% | -92.4% | |
| – | -59.1% | -47.7% | -11.9% | -56.8% | -49.0% | -54.0% | +212.4% | +23.5% | -14.9% | +39.2% | -92.4% | |
| – | – | +40.6% | -28.9% | +51.6% | – | – | -68.6% | +142.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.7% | -65.3% | +30.5% | +1,554.0% | +0.3% | +42.6% | +112.3% | +47.2% | +1.4% | -34.1% | +3.7% | |
| – | -97.7% | -65.3% | +30.5% | +1,554.0% | +0.3% | +42.6% | +112.3% | +47.2% | +1.4% | -34.1% | +3.7% | |
| – | – | – | – | -33.3% | – | – | -60.0% | +0.0% | – | – | – | |
| – | -99.2% | -100.0% | – | – | – | – | -41.7% | -30.9% | +9,752.3% | -97.3% | -44.9% | |
| – | -10.1% | -6.1% | -49.7% | -82.5% | -80.7% | -1,373.9% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.9% | +3.1% | -1.1% | +1.3% | -1.3% | -0.1% | +2.6% | +2.4% | +10.9% | +2.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.